Human epidermal growth factor receptor 2 Positive Breast Cancer
Showing 9976 - 10000 of >10,000
Using Diffuse Optical Spectroscopic Imaging
Withdrawn
- Breast Cancer
- Diffuse Optical Spectroscopy Imaging
-
Irvine, CaliforniaBeckman Laser Institute
Oct 28, 2022
Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)
Recruiting
- Hematological Malignancy
- Cancer-Related Anemia
- Shengxuening Tablet
- Ferrous succinate
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Mar 13, 2023
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)
Recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 23, 2022
Eswatini After Transition To Dolutegravir-Based Treatment
Recruiting
- Neural Tube Defects
- +2 more
-
Lubombo, Swaziland
- +4 more
May 22, 2023
Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT
Not yet recruiting
- Multiple Myeloma
- Dara-VRd intensification, Dara-R maintenance
- +4 more
- (no location specified)
Dec 13, 2022
Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)
Recruiting
- Gastric Cancer
- Serplulimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 27, 2023
Cognition in Older Breast Cancer Survivors: Treatment Exposure,
Active, not recruiting
- Breast Cancer Survivors
-
Duarte, California
- +1 more
May 20, 2022
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +
Recruiting
- Gastric Cancer
- +9 more
- Tumor Infiltrating Lymphocytes (TIL)
- Fludarabine + Cyclophosphamide combination
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
Breast Tumor, Inflammatory Breast Carcinoma Trial in Houston (Photoacoustic Imaging)
Terminated
- Breast Neoplasm
- Inflammatory Breast Carcinoma
- Photoacoustic Imaging
-
Houston, TexasM D Anderson Cancer Center
Jun 24, 2021
Renal Cell Carcinoma Metastatic Trial in France (KidneyPRO, standard follow-up)
Recruiting
- Renal Cell Carcinoma Metastatic
- KidneyPRO
- standard follow-up
-
Angers, France
- +12 more
May 2, 2022
Apnea During Procedural Sedation Trial (Noninvasive Ventilator (V60, Philips))
Completed
- Apnea During Procedural Sedation
- Noninvasive Ventilator (V60, Philips)
- (no location specified)
Apr 26, 2021
Adolescent Behavior, Adolescent Problem Behavior, Risk Reduction Trial (Tennessee Youth Prepared for Success)
Not yet recruiting
- Adolescent Behavior
- +2 more
- Tennessee Youth Prepared for Success
- (no location specified)
Aug 17, 2023
Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)
Not yet recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- CodaLytic
-
Boston, Massachusetts
- +1 more
Oct 28, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory
Completed
- Advanced Malignant Solid Neoplasm
- +3 more
- Laboratory Biomarker Analysis
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 21, 2022
Low Back Pain Trial in Madinat al Fayyum (intra-articular Platelet rich fibrin and lidocaine, methylprednisolone acetate and
Recruiting
- Low Back Pain
- intra-articular Platelet rich fibrin and lidocaine
- methylprednisolone acetate and lidocaine
-
Madīnat al Fayyūm, Faiyum Governorate, EgyptFayoum University hospital
Jul 25, 2022
COVID-19 Trial in Changde, Changning, Zhuzhou (Omicron COVID-19 Vaccine (Vero Cell), Inactivated, COVID-19 Vaccine (Vero Cell),
Recruiting
- COVID-19
- Omicron COVID-19 Vaccine (Vero Cell), Inactivated
- COVID-19 Vaccine (Vero Cell), Inactivated
-
Changde, Hunan, China
- +2 more
May 30, 2022
Hypertension Trial in Guangzhou (Nicotinamide mononucleotide supplied as 400mg capsule, Lifestyle modification)
Recruiting
- Hypertension
- Nicotinamide mononucleotide supplied as 400mg capsule
- Lifestyle modification
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital,Sun Yat-sen University
Jan 17, 2022
Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
Not yet recruiting
- Relapsing Multiple Sclerosis
- No intervention
- (no location specified)
Nov 16, 2023
Bioequivalence Trial in Chennai (Levodopa 250mg and Carbidopa 25mg Test Drug tablet, Levodopa 250mg and Carbidopa 25mg Referent
Completed
- Bioequivalence
- Levodopa 250mg and Carbidopa 25mg Test Drug tablet
- Levodopa 250mg and Carbidopa 25mg Referent Product tablet
-
Chennai, Tamil Nadu, IndiaAzidus Laboratories Ltd.
Mar 7, 2022
Skin Condition Trial in Cheras, Petaling Jaya (Rice ceramide supplementation)
Completed
- Skin Condition
- Rice ceramide supplementation
-
Cheras, Kuala Lumpur, Malaysia
- +1 more
Sep 27, 2022
Refractory Malignant Solid Tumor Trial (PCNA Inhibitor AOH1996)
Recruiting
- Refractory Malignant Solid Neoplasm
- PCNA Inhibitor AOH1996
-
Scottsdale, Arizona
- +1 more
Sep 29, 2022
Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Urothelial Carcinoma, Metastatic Renal Cell Carcinoma Trial
Completed
- Metastatic Castration-resistant Prostate Cancer (mCRPC)
- +2 more
- Isovue-M 200
-
Durham, North CarolinaDuke University Medical Center
Apr 1, 2022
Hepatocellular Carcinoma Trial in Yerevan
Recruiting
- Hepatocellular Carcinoma
-
Yerevan, ArmeniaNikomed Medical Center
Jun 28, 2023
Rectal Cancer Stage III, Rectal Cancer Stage IV Trial in Beijing (procedure, drug, device, diagnostic test)
Not yet recruiting
- Rectal Cancer Stage III
- Rectal Cancer Stage IV
- Sentinel lymph node biopsy
- +5 more
-
Beijing, Beijing, ChinaNational Cancer Center
Apr 26, 2023